Citation: | CHEN Jia-bin, ZHANG Meng-yao, WANG Dan, HUANG Tong-xing, SHAN Jin-jun, YANG Jun-chao, SONG Kang, LIN Li-li. Study on Lipid Metabolism Regulated by Polygonum Cuspidatum in the Treatment of Pulmonary Fibrosis Model of Respiratory Syncytial Virus Infection in Mice[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(7): 618-628. doi: 10.14148/j.issn.1672-0482.2023.0618 |
[1] |
LI Y, WANG X, BLAU DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: A systematic analysis[J]. Lancet, 2022, 399(10340): 2047-2064. doi: 10.1016/S0140-6736(22)00478-0
|
[2] |
SHI T, DENOUEL A, TIETJEN AK, et al. Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: A systematic review and meta-analysis[J]. J Infect Dis, 2020, 222(S7): S577-S583.
|
[3] |
SOMAYAJI R, GOSS CH, KHAN U, et al. Cystic fibrosis pulmonary exacerbations attributable to respiratory syncytial virus and influenza: A population-based study[J]. Clin Infect Dis, 2017, 64(12): 1760-1767. doi: 10.1093/cid/cix203
|
[4] |
WANG LN, CHENG W, ZHANG ZM. Respiratory syncytial virus infection accelerates lung fibrosis through the unfolded protein response in a bleomycin-induced pulmonary fibrosis animal model[J]. Mol Med Rep, 2017, 16(1): 310-316. doi: 10.3892/mmr.2017.6558
|
[5] |
BALGOMA D, GIL-DE-GOMEZ L, MONTERO O. Lipidomics issues on human positive ssRNA virus infection: An update[J]. Metabolites, 2020, 10(9): 356. doi: 10.3390/metabo10090356
|
[6] |
李柏颖. 清热解毒澄其源: 宋康教授治疗特发性肺纤维化经验介绍[J]. 浙江中西医结合杂志, 2008, 18(6): 359-360. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJZH200806016.htm
LI BY. Clearing away heat and toxic materials to clarify its source: Introduction of Professor Song Kang's experience in treating idiopathic pulmonary fibrosis[J]. Zhejiang J Integr Tradit Chin West Med, 2008, 18(6): 359-360. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJZH200806016.htm
|
[7] |
宋康, 骆仙芳, 杨珺超, 等. 虎杖对肺纤维化大鼠肺组织中TGF-β1表达的影响[J]. 中华中医药杂志, 2007, 22(12): 888-891. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY200712024.htm
SONG K, LUO XF, YANG JC, et al. Effect of Rhizoma Polygoni Cuspidati on expression of TGF-β1 in rats with pulmonary fibrosis[J]. China J Tradit Chin Med Pharm, 2007, 22(12): 888-891. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY200712024.htm
|
[8] |
陈奇. 中药药理研究方法学[M]. 2版. 北京: 人民卫生出版社, 2006: 33.
CHEN Q. Methodology of Pharmacological Research of Traditional Chinese Medicine[M]. 2nd ed. Beijing: People's medical publishing house, 2006: 33.
|
[9] |
纪建建, 杨瑞, 谢彤, 等. 基于高分辨率质谱的金欣口服液治疗小鼠RSV感染的血清脂质组学研究[J]. 南京中医药大学学报, 2019, 35(1): 78-84. http://xb.njucm.edu.cn/article/id/zr20190118
JI JJ, YANG R, XIE T, et al. Lipomics study of Jinxin oral liquid for RSV infection in mice based on UHPLC-Q-exactive orbitrap/MS[J]. J Nanjing Univ Tradit Chin Med, 2019, 35(1): 78-84. http://xb.njucm.edu.cn/article/id/zr20190118
|
[10] |
王璇, 徐泳, 罗子宸, 等. 基于网络药理学探索桔梗治疗肺纤维化的作用机制[J]. 药学学报, 2021, 56(11): 2957-2967. https://www.cnki.com.cn/Article/CJFDTOTAL-YXXB202111010.htm
WANG X, XU Y, LUO ZC, et al. Mechanism of Platycodon grandiflorum in the treatment of pulmonary fibrosis based on network pharmacology[J]. Acta Pharm Sin, 2021, 56(11): 2957-2967. https://www.cnki.com.cn/Article/CJFDTOTAL-YXXB202111010.htm
|
[11] |
MEYER KC. Pulmonary fibrosis, part Ⅰ: Epidemiology, pathogenesis, and diagnosis[J]. Expert Rev Respir Med, 2017, 11(5): 343-359.
|
[12] |
THANNICKAL VJ, TOEWS GB, WHITE ES, et al. Mechanisms of pulmonary fibrosis[J]. Annu Rev Med, 2004, 55: 395-417. doi: 10.1146/annurev.med.55.091902.103810
|
[13] |
AN L, LU MJ, XU WC, et al. Qingfei oral liquid alleviates RSV-induced lung inflammation by promoting fatty-acid-dependent M1/M2 macrophage polarization via the Akt signaling pathway[J]. J Ethnopharmacol, 2022, 298: 115637. doi: 10.1016/j.jep.2022.115637
|
[14] |
GROSS R, HAN XL. Lipidomics at the interface of structure and function in systems biology[J]. Chem Biol, 2011, 18(3): 284-291. doi: 10.1016/j.chembiol.2011.01.014
|
[15] |
SURYADEVARA V, RAMCHANDRAN R, KAMP DW, et al. Lipid mediators regulate pulmonary fibrosis: Potential mechanisms and signaling pathways[J]. Int J Mol Sci, 2020, 21(12): 4257. doi: 10.3390/ijms21124257
|
[16] |
BURGY O, LORIOD S, BELTRAMO G, et al. Extracellular lipids in the lung and their role in pulmonary fibrosis[J]. Cells, 2022, 11(7): 1209. doi: 10.3390/cells11071209
|
[17] |
HUANG LS, SUDHADEVI T, FU PF, et al. Sphingosine kinase 1/S1P signaling contributes to pulmonary fibrosis by activating hippo/YAP pathway and mitochondrial reactive oxygen species in lung fibroblasts[J]. Int J Mol Sci, 2020, 21(6): 2064.
|
[18] |
HO LTY, SKIBA N, ULLMER C, et al. Lysophosphatidic acid induces ECM production via activation of the mechanosensitive YAP/TAZ transcriptional pathway in trabecular meshwork cells[J]. Invest Ophthalmol Vis Sci, 2018, 59(5): 1969-1984.
|
[19] |
ROMERO F, SHAH D, DUONG M, et al. A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis[J]. Am J Respir Cell Mol Biol, 2015, 53(1): 74-86.
|